Pfizer Inc Stock Net Income
| PFE Stock | EUR 23.37 0.05 0.21% |
As of the 13th of February 2026, Pfizer holds the Coefficient Of Variation of 819.29, semi deviation of 1.38, and Risk Adjusted Performance of 0.1039. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Please check Pfizer Inc variance, jensen alpha, and the relationship between the standard deviation and information ratio to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 23.37 per share.
Pfizer Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.2414 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 9.3 B | 14.3 B | |
| Net Income Applicable To Common Shares | 36.1 B | 37.9 B | |
| Net Income | 9.2 B | 14.5 B | |
| Net Income Per Share | 1.37 | 0.94 | |
| Net Income Per E B T | 1.03 | 0.70 |
Pfizer | Net Income |
The Net Income trend for Pfizer Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pfizer is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pfizer's Net Income Growth Pattern
Below is the plot of the Net Income of Pfizer Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pfizer Inc financial statement analysis. It represents the amount of money remaining after all of Pfizer Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pfizer's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 8.03 B | 10 Years Trend |
|
Net Income |
| Timeline |
Pfizer Net Income Regression Statistics
| Arithmetic Mean | 12,085,455,882 | |
| Geometric Mean | 10,374,655,925 | |
| Coefficient Of Variation | 58.61 | |
| Mean Deviation | 5,296,567,128 | |
| Median | 9,135,000,000 | |
| Standard Deviation | 7,083,111,071 | |
| Sample Variance | 50170462.4T | |
| Range | 29.3B | |
| R-Value | 0.24 | |
| Mean Square Error | 50500872.5T | |
| R-Squared | 0.06 | |
| Significance | 0.36 | |
| Slope | 332,895,466 | |
| Total Sum of Squares | 802727399.1T |
Pfizer Net Income History
Pfizer Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Pfizer Stock properly, considering its historical fundamentals such as Net Income. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.
Click cells to compare fundamentals
Pfizer 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pfizer's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pfizer.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Pfizer on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Pfizer Inc or generate 0.0% return on investment in Pfizer over 90 days. Pfizer is related to or competes with Boston Scientific. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide More
Pfizer Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pfizer's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pfizer Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.56 | |||
| Information Ratio | 0.0699 | |||
| Maximum Drawdown | 8.13 | |||
| Value At Risk | (1.80) | |||
| Potential Upside | 2.77 |
Pfizer Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pfizer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pfizer's standard deviation. In reality, there are many statistical measures that can use Pfizer historical prices to predict the future Pfizer's volatility.| Risk Adjusted Performance | 0.1039 | |||
| Jensen Alpha | 0.1894 | |||
| Total Risk Alpha | 0.0441 | |||
| Sortino Ratio | 0.0693 | |||
| Treynor Ratio | (1.20) |
Pfizer February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1039 | |||
| Market Risk Adjusted Performance | (1.19) | |||
| Mean Deviation | 1.16 | |||
| Semi Deviation | 1.38 | |||
| Downside Deviation | 1.56 | |||
| Coefficient Of Variation | 819.29 | |||
| Standard Deviation | 1.55 | |||
| Variance | 2.39 | |||
| Information Ratio | 0.0699 | |||
| Jensen Alpha | 0.1894 | |||
| Total Risk Alpha | 0.0441 | |||
| Sortino Ratio | 0.0693 | |||
| Treynor Ratio | (1.20) | |||
| Maximum Drawdown | 8.13 | |||
| Value At Risk | (1.80) | |||
| Potential Upside | 2.77 | |||
| Downside Variance | 2.43 | |||
| Semi Variance | 1.92 | |||
| Expected Short fall | (1.26) | |||
| Skewness | 0.077 | |||
| Kurtosis | 0.955 |
Pfizer Inc Backtested Returns
At this point, Pfizer is very steady. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Pfizer Inc, which you can use to evaluate the volatility of the company. Please check Pfizer's Coefficient Of Variation of 819.29, semi deviation of 1.38, and Risk Adjusted Performance of 0.1039 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Pfizer has a performance score of 7 on a scale of 0 to 100. The company holds a Beta of -0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pfizer are expected to decrease at a much lower rate. During the bear market, Pfizer is likely to outperform the market. Pfizer Inc right now holds a risk of 1.51%. Please check Pfizer Inc coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the information ratio and total risk alpha , to decide if Pfizer Inc will be following its historical price patterns.
Auto-correlation | -0.59 |
Good reverse predictability
Pfizer Inc has good reverse predictability. Overlapping area represents the amount of predictability between Pfizer time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pfizer Inc price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Pfizer price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.59 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.35 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pfizer Operating Income
Operating Income |
|
Based on the recorded statements, Pfizer Inc reported net income of 8.03 B. This is much higher than that of the Pharmaceuticals sector and 97.01% higher than that of the Health Care industry. The net income for all Germany stocks is significantly lower than that of the firm.
Pfizer Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pfizer from analyzing Pfizer's financial statements. These drivers represent accounts that assess Pfizer's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pfizer's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 208.9B | 205.4B | 286.8B | 142.0B | 127.8B | 150.8B |
Pfizer ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pfizer's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pfizer's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Pfizer Fundamentals
| Return On Equity | 0.0858 | ||||
| Return On Asset | 0.0519 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 170.41 B | ||||
| Shares Outstanding | 5.69 B | ||||
| Shares Owned By Insiders | 0.07 % | ||||
| Shares Owned By Institutions | 67.83 % | ||||
| Price To Earning | 16.17 X | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 2.12 X | ||||
| Revenue | 63.63 B | ||||
| Gross Profit | 47.44 B | ||||
| EBITDA | 25.69 B | ||||
| Net Income | 8.03 B | ||||
| Cash And Equivalents | 11.7 B | ||||
| Cash Per Share | 2.10 X | ||||
| Total Debt | 6.95 B | ||||
| Debt To Equity | 78.80 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | 13.73 X | ||||
| Cash Flow From Operations | 12.74 B | ||||
| Earnings Per Share | 1.14 X | ||||
| Price To Earnings To Growth | 3.79 X | ||||
| Number Of Employees | 81 K | ||||
| Beta | 0.44 | ||||
| Market Capitalization | 132.59 B | ||||
| Total Asset | 213.4 B | ||||
| Retained Earnings | 116.72 B | ||||
| Working Capital | 7.36 B | ||||
| Annual Yield | 0.06 % | ||||
| Five Year Return | 3.17 % | ||||
| Net Asset | 213.4 B | ||||
| Last Dividend Paid | 1.72 |
About Pfizer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.